Cure Alzheimer's Fund Expands Board with Experienced Leaders Driven by Personal Connection to Disease

Cure Alzheimer's Fund has added three accomplished business leaders to its Board of Directors, each bringing unique expertise and a deeply personal commitment to fighting Alzheimer's disease. Mary Greenhill Cagliero, Mark Faggiano, and Kumar Mahadeva join the nonprofit's board, bringing strategic leadership and personal experiences that align with the organization's mission to prevent, slow, or reverse Alzheimer's.

The new board members represent a cross-section of professional excellence, with backgrounds spanning technology, entrepreneurship, and finance. Their appointments signal the organization's strategic approach to expanding its research and fundraising capabilities while maintaining a deeply empathetic connection to the disease's impact.

Mary Greenhill Cagliero, with a background in investment banking and entrepreneurship, brings financial acumen and personal understanding to the board. Her mother's battle with Alzheimer's provides a poignant motivation for her involvement. Similarly, Mark Faggiano, a successful technology entrepreneur known for leading TaxJar to a significant acquisition, joins the board after losing his father to the disease in 2021.

Kumar Mahadeva, founder of Cognizant Technology Solutions and an experienced business leader, rounds out the new board members. His personal experience of losing his father to Alzheimer's in 2013 further underscores the board's shared commitment to finding meaningful solutions.

Since its founding in 2004, Cure Alzheimer's Fund has been a significant force in Alzheimer's research, providing 927 grants totaling more than $223 million to over 300 leading researchers worldwide. The organization has consistently received top ratings from nonprofit evaluators, including a perfect score from Charity Navigator for 13 consecutive years.

These strategic board appointments represent more than a leadership expansion; they symbolize a continued dedication to understanding and ultimately defeating a disease that affects millions of families globally. By combining professional expertise with personal passion, Cure Alzheimer's Fund reinforces its commitment to driving transformative research and hope for those impacted by Alzheimer's.